Inside the Hidden World of Phase 1 Drug Testing

August 11, 2020

AJMC interviews Jill A. Fisher, PhD, author of a new book, Adverse Events: Race, Inequality, and the Testing of New Pharmaceuticals. Her research took her inside clinical testing sites for phase 1 drug studies.

Experts Highlight COVID-19 Vaccine Developments and Remaining Challenges

August 04, 2020

The coronavirus disease 2019 (COVID-19) vaccines that are leading the pack are utilizing a new vaccine technology that has never been approved for human use by the FDA. As a result, there are a lot of unknowns.

Hospitals Vow to Fight Court of Appeals 340B Ruling

August 03, 2020

The ruling reversed a lower court ruling regarding the drug discount program for hospitals that serve patients covered by Medicaid.

Study Highlights Variation in Second-Generation Diabetes Drug Use Among Medicare Enrollees

June 22, 2020

Among Medicare enrollees, there was substantial between-practice variation in the use of second-generation diabetes drugs between 2007 and 2015, according to a study published in JAMA Network Open. Data also revealed a concentration of use among a few prescribers and practices, who were responsible for widespread early diffusion.

Study Highlights Rapid Increase of Inpatient Migraine Cost Burden

June 01, 2020

Between 1997 and 2012, the inpatient burden of migraine cost rapidly increased in the United States, according to a study published in PRS Global Open.

How Comorbidities Affect Costs and Costs Impact Nonadherence in RA

May 29, 2020

For patients with rheumatoid arthritis (RA), cost can play a role in patient adherence to medication, but the presence of comorbidities does not impact cost of care for patients, according to 2 abstracts presented at the Virtual 2020 International Society for Pharmacoeconomics and Outcomes Research meeting.

Second-Line Therapies in Parkinson Disease Aim to Maximize Outcomes, but at a Price

May 27, 2020

According to study findings, continuous duodenal levodopa/carbidopa infusion was indicated as the most expensive second-line therapy in advanced stage Parkinson disease compared with deep brain stimulation and continuous subcutaneous apomorphine infusion.

Dr Ray Page on Balancing Innovations and Cost in Cancer Care

May 05, 2020

Transformational changes in cancer care can bring forth important innovations, but all those come at a cost, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.

Aligning Employer, Patient Needs: How Integrating Patient-Centered Care Can Promote Greater Value From Healthcare Spending

March 18, 2020

In a webinar moderated by Thomas Parry, PhD, president of the Integrated Benefits Institute, an employer panel discussed value, application, and barriers to strategies involving the integration of employee needs and interests into benefit programs.